Vasopressin & SNP Flashcards
Arginine vasopressin
endogenous hormone
ADH
produced in hypothalamus stores in posterior pituitary
ADH role
osmoregulation: release stimulated by increased osmolarity and hypovolemia
potent vasoconstrictor, but dilates renal afferent, pulmonary and cerebral arterioles
3 Types Vasopressin Receptors
V1, V2, V3
V1
mediates vasoconstriction (vasculature)
V2
mediates water reabsorption in the renal collecting ducts (kidney)
V3
found in CNS and stimulates modulation of corticotrophin secretion
Vasopressin Uses
post cardiopulm bypass shock refractory hypotension (ACE & ARB DOS) Reduce bleeding in VWB disease anti-diuresis in DI treatment of enuresis
Vasopressin Dosage
low dose infusion: 0.03-0.04 units/min, max 0.1 units/min bolus IV 1-2 units onset: 1-5 min DOA: 10-30 min peak effect: 5 min
Vasopressin Complications
only seen at dosages >0.04 units/min
GI ischemia
decreased CO
skin or digital necrosis
Peripheral Vasodilators: SNP
direct acting, nonselective peripheral vasodilator
relaxation of arterial and venous VSM
lacks significant effects on nonvascular SM and cardiac muscle
SNP MOA
SNP interacts with oxyhemoglobin to form methemoglobin, NO and cyanide
NO activates guanylate cyclase (increasing cGMP)
SNP Metabolism
transfer of an electron from iron of oxyhemoglobin to SNP yields metHgb and an UNSTABLE SNP radical, this breaks down to release 5 cyanide ions.
ONE cyanide ion interacts with metHGB to form cyano-methemoglobin (nontoxic)
remainder metabolized in liver and kidney and converted to thiocyanate
SNP Toxicity
occurs due to the effects of high plasma concentrations of THIOCYANATE
Cyanide Toxicity
occurs at rates >2mcg/kg/min for LONG PERIODS
suspect this when patients have resistance to hypotensive effects or previously responsive patient who is unresponsive (tachyphylaxis) rates >2-10 mcg/kg/min
May precipitate tissue anoxia, anaerobic metabolism and lactic acidosis